Susquehanna International Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.4M Sell
600,889
-144,605
-19% -$8.43M ﹤0.01% 1554
2025
Q4
$40.2M Sell
745,494
-1,532,662
-67% -$73.7M ﹤0.01% 1557
2025
Q3
$103M Buy
2,278,156
+490,174
+27% +$22.9M 0.01% 881
2025
Q2
$82.8M Buy
1,787,982
+1,368,125
+326% +$67.2M 0.01% 864
2025
Q1
$25.6M Sell
419,857
-878,257
-68% -$51.2M ﹤0.01% 1521
2024
Q4
$73.4M Buy
1,298,114
+106,238
+9% +$5.94M 0.01% 883
2024
Q3
$61.7M Sell
1,191,876
-2,776,289
-70% -$130M 0.01% 941
2024
Q2
$165M Buy
3,968,165
+2,494,944
+169% +$112M 0.03% 416
2024
Q1
$79.9M Sell
1,473,221
-781,065
-35% -$39.8M 0.01% 775
2023
Q4
$116M Buy
2,254,286
+1,121,402
+99% +$58.9M 0.02% 611
2023
Q3
$65.8M Sell
1,132,884
-151,362
-12% -$9.27M 0.01% 840
2023
Q2
$82.1M Sell
1,284,246
-263,187
-17% -$17.6M 0.02% 711
2023
Q1
$107M Sell
1,547,433
-322,958
-17% -$22.8M 0.02% 556
2022
Q4
$135M Buy
1,870,391
+1,688,211
+927% +$127M 0.03% 447
2022
Q3
$13M Sell
182,180
-401,414
-69% -$29.1M ﹤0.01% 1861
2022
Q2
$44.9M Buy
583,594
+41,303
+8% +$3.15M 0.01% 909
2022
Q1
$39.6M Sell
542,291
-1,941,010
-78% -$130M 0.01% 1153
2021
Q4
$155M Sell
2,483,301
-802,021
-24% -$47M 0.02% 545
2021
Q3
$194M Buy
3,285,322
+1,665,265
+103% +$110M 0.03% 528
2021
Q2
$108M Buy
1,620,057
+19,591
+1% +$1.28M 0.02% 752
2021
Q1
$101M Sell
1,600,466
-37,901
-2% -$2.36M 0.02% 731
2020
Q4
$102M Buy
1,638,367
+1,533,863
+1,468% +$94.3M 0.02% 653
2020
Q3
$6.3M Sell
104,504
-886,354
-89% -$53.3M ﹤0.01% 2773
2020
Q2
$58.3M Sell
990,858
-377,351
-28% -$22.6M 0.01% 746
2020
Q1
$76.3M Sell
1,368,209
-3,204,144
-70% -$196M 0.02% 486
2019
Q4
$294M Buy
4,572,353
+1,364,167
+43% +$78.1M 0.08% 190
2019
Q3
$163M Sell
3,208,186
-2,044,994
-39% -$96.1M 0.05% 294
2019
Q2
$238M Buy
5,253,180
+1,779,078
+51% +$82.9M 0.09% 189
2019
Q1
$166M Buy
3,474,102
+3,353,663
+2,785% +$167M 0.07% 238
2018
Q4
$6.26M Buy
120,439
+36,014
+43% +$1.93M ﹤0.01% 2049
2018
Q3
$5.24M Sell
84,425
-2,269,576
-96% -$135M ﹤0.01% 2635
2018
Q2
$130M Buy
2,354,001
+1,278,845
+119% +$69.1M 0.04% 336
2018
Q1
$68M Buy
1,075,156
+922,802
+606% +$59.4M 0.02% 531
2017
Q4
$9.34M Sell
152,354
-541,636
-78% -$33.9M ﹤0.01% 1881
2017
Q3
$44.2M Sell
693,990
-438,492
-39% -$25.6M 0.02% 698
2017
Q2
$63.1M Sell
1,132,482
-1,800,761
-61% -$98M 0.03% 509
2017
Q1
$160M Buy
2,933,243
+1,046,043
+55% +$57.4M 0.08% 220
2016
Q4
$110M Sell
1,887,200
-2,572,211
-58% -$141M 0.06% 301
2016
Q3
$240M Buy
+4,459,411
New +$286M 0.12% 138
2016
Q2
Sell
-57,316
Closed -$4.05M 8542
2016
Q1
$3.66M Sell
57,316
-19,825
-26% -$1.25M ﹤0.01% 2743
2015
Q4
$5.31M Sell
77,141
-779,632
-91% -$51.5M ﹤0.01% 2460
2015
Q3
$50.7M Buy
856,773
+528,323
+161% +$33.5M 0.02% 624
2015
Q2
$21.9M Buy
328,450
+148,721
+83% +$9.8M 0.01% 1229
2015
Q1
$11.6M Sell
179,729
-61,783
-26% -$3.87M 0.01% 1726
2014
Q4
$14.3M Sell
241,512
-720,912
-75% -$40.7M 0.01% 1641
2014
Q3
$49.3M Sell
962,424
-788,055
-45% -$39.4M 0.02% 760
2014
Q2
$84.9M Buy
1,750,479
+1,536,779
+719% +$75.7M 0.04% 432
2014
Q1
$11.1M Sell
213,700
-2,176,927
-91% -$116M 0.01% 1903
2013
Q4
$127M Buy
2,390,627
+974,439
+69% +$49.6M 0.06% 278
2013
Q3
$65.5M Buy
1,416,188
+105,935
+8% +$4.65M 0.03% 477
2013
Q2
$58.6M Buy
+1,310,253
New +$56.9M 0.03% 487

Other funds holding BMY

Susquehanna International Group's BMY Position: Q1 2026 in Review

Susquehanna International Group reduced its Bristol-Myers Squibb (BMY) stake by 19% in Q1 2026, selling an estimated $8.43M and leaving 600,889 shares worth $36.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1554.

Susquehanna International Group first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $294M in Q4 2019. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Susquehanna International Group held 600,889 shares of Bristol-Myers Squibb worth $36.4M as of Q1 2026.
  • Susquehanna International Group sold 144,605 Bristol-Myers Squibb shares in Q1 2026, an estimated $8.43M.
  • Bristol-Myers Squibb made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1554 holding.
  • Susquehanna International Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
  • Susquehanna International Group's Bristol-Myers Squibb position peaked at $294M in Q4 2019.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.